Renslow Sherer to Anti-HIV Agents
This is a "connection" page, showing publications Renslow Sherer has written about Anti-HIV Agents.
Connection Strength
1.653
-
Generic antiretrovirals and the uncertain future of HIV care in the United States. Ann Intern Med. 2013 Jan 15; 158(2):133-4.
Score: 0.318
-
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China. Sex Health. 2026 Feb 05; 23(1).
Score: 0.197
-
The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey. AIDS Patient Care STDS. 2005 Dec; 19(12):794-802.
Score: 0.194
-
HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China. Sex Health. 2025 03; 22.
Score: 0.184
-
Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence Among Men Who Have Sex with Men: A Cohort Study in China. AIDS Behav. 2025 Jun; 29(6):1831-1840.
Score: 0.184
-
Acute facial neuralgia related to initiation of emtricitabine/tenofovir for HIV PrEP: a report of two cases in a PrEP demonstration trial. Sex Health. 2024 01; 21.
Score: 0.170
-
Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000 Jun; 30 Suppl 2:S96-116.
Score: 0.133
-
Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting. Semin Oncol. 1998 Apr; 25(2 Suppl 6):92-7.
Score: 0.114
-
HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS Treatment for Life International Survey. J Int Assoc Physicians AIDS Care (Chic). 2012 Mar-Apr; 11(2):128-33.
Score: 0.075
-
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients. J Infect Dis. 2004 Jul 15; 190(2):280-4.
Score: 0.044
-
Improving adherence to antiretroviral therapy. AIDS Read. 2003 Feb; 13(2):81-2, 85-6, 88-90.
Score: 0.040